查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1594331

分子品管市場：按產品類型、分析物類型、應用、最終用戶 - 2025-2030 年全球預測

Molecular Quality Controls Market by Product (Independent Controls, Instrument-Specific Controls), Analyte Type (Multi-Analyte Controls, Single-Analyte Controls), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年分子品管市場價值為2.0125億美元，預計到2024年將達到2.1787億美元，複合年成長率為8.74%，到2030年將達到3.6187億美元。

分子品管對於確保在臨床實驗室中發揮關鍵作用的分子診斷測試的準確性和可靠性至關重要。這些控制對於檢驗診斷分析的性能、實驗室之間的基準一致性以及支援監管機構的認證要求是必要的。其應用範圍廣泛，包括傳染病檢查、癌症診斷、基因檢測、個人化醫療等，在臨床實驗室、研究機構和醫院中不可或缺。推動市場的主要成長要素包括分子診斷的技術進步、感染疾病病率的增加以及個人化醫療的日益採用。對醫療保健領域監管合規性和品質保證的日益關注進一步推動了需求。由於醫療投資的增加和檢測能力的擴大，新興市場提供了商機。然而，品管產品高成本、發展中地區意識淡薄以及嚴格的監管環境等挑戰可能會阻礙成長。公司可以透過創新具有成本效益的解決方案並透過策略聯盟和培訓計劃提高知名度來抓住機會。在開發與自動化平台相容的整合控制解決方案、增加復用能力以及提高控制穩定性和保存期限方面存在巨大的創新潛力。此外，透過開發可客製化的、針對特異性疾病的品管方法，我們可以更好地滿足市場需求。市場競爭激烈，整合趨勢透過策略併購提供了成長機會。參與企業必須確保適應不斷發展的技術和監管環境，以保持競爭力。此外，我們可以透過與診斷公司合作提供量身定做的解決方案來擴大我們的影響力和影響力。加快對新型生物標記和數位平台的研究將支持提高競爭力和診斷準確性的總體目標。在這些動態的作用下，利用技術進步和對當地市場需求的敏銳了解的敏捷方法可能會導致該市場的業務成功。

主要市場統計
基準年[2023] 20125萬美元
預測年份 [2024] 21787萬美元
預測年份 [2030] 36187萬美元
複合年成長率（%） 8.74%

市場動態：揭示快速發展的分子品管市場的關鍵市場洞察

分子品管市場正因供需的動態交互作用而轉變。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 感染疾病高發生率和疾病檢測的必要性
    • 基因組學的政府津貼和資助
    • 臨床實驗室數量增加，多項目檢測需求增加
  • 市場限制因素
    • 不利的報銷情況和品管的額外成本
  • 市場機會
    • 對個人化醫療和第三方品管的日益偏好
    • 隨著分子測試的發展，可能性越來越大
  • 市場挑戰
    • 品管物資匱乏，檢測系統定量產出，新的基因檢測標靶每天層出不窮

波特五力：駕馭分子品管市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解分子品管市場的外部影響

外部宏觀環境因素在塑造分子品管市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解分子品管市場的競爭格局

對分子品管市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣分子品管市場供應商績效評估

FPNV 定位矩陣是評估分子品管市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了分子品管市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，分子品管市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 感染疾病的傳播和檢測的必要性
      • 基因組學的政府津貼和資助
      • 臨床實驗室數量增加，多專案檢測管理需求增加
    • 抑制因素
      • 不利的報銷情況和品管的額外成本
    • 機會
      • 對個人化醫療和第三方品管的興趣日益濃厚
      • 隨著分子測試的發展，機會也在增加
    • 任務
      • 缺乏品管材料、定量檢測系統輸出，新的基因檢測標靶每天都在出現
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章分子品管市場：依產品

  • 獨立控制
  • 儀器特定控制

第7章依分析物類型分類的分子品管市場

  • 多分析物控制
  • 單一分析物對照

第8章分子品管市場：依應用分類

  • 基因檢測
  • 感染疾病
  • 腫瘤學

第9章分子品管市場：按最終用戶

  • 學術研究所
  • 臨床實驗室
  • 醫院
  • IVD 製造商和合約研究機構

第10章美洲分子品管市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太分子品管市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲的分子品管市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Anchor Molecular Inc.
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Fortress Diagnostics
  • Grifols SA
  • LGC Limited
  • Maine Molecular Quality Controls, Inc.
  • Microbiologics, Inc.
  • Microbix Biosystems Inc.
  • Qnostics Ltd.
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Seegene, Inc.
  • SpeeDx Pty Ltd.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-5A2C6AA667CA

The Molecular Quality Controls Market was valued at USD 201.25 million in 2023, expected to reach USD 217.87 million in 2024, and is projected to grow at a CAGR of 8.74%, to USD 361.87 million by 2030.

Molecular Quality Controls are essential in ensuring the accuracy and reliability of molecular diagnostic tests, which play a critical role in clinical laboratory settings. These controls are necessary for validating the performance of diagnostic assays, benchmarking inter-laboratory consistency, and supporting accreditation requirements by regulatory bodies. Their applications span infectious disease testing, cancer diagnostics, genetic testing, and personalized medicine, making them indispensable in clinical laboratories, research institutions, and hospitals. Key growth factors driving the market include technological advancements in molecular diagnostics, the rising prevalence of infectious diseases, and the increasing adoption of personalized medicine. The growing focus on regulatory compliance and quality assurance in healthcare further fuels demand. Emerging markets present opportunities due to heightened healthcare investments and expanding testing capacities. However, challenges such as the high cost of quality control products, limited awareness in developing regions, and stringent regulatory landscapes may hinder growth. Companies can capitalize on opportunities by innovating cost-effective solutions and increasing awareness through strategic collaborations and training programs. There is immense potential for innovation in developing integrated control solutions compatible with automated platforms, enhancing multiplexing capabilities, and improving the stability and shelf life of controls. Moreover, creating customizable and disease-specific quality controls can meet precise market needs. The nature of the market is competitive, with consolidation trends presenting opportunities for growth through strategic mergers and acquisitions. Entrants must ensure adaptability to evolving technological and regulatory landscapes to maintain competitiveness. Furthermore, collaborating with diagnostic companies to provide tailor-made solutions could also expand reach and influence. Fostering research into novel biomarkers and digital platforms could provide a competitive edge and support the overarching goal of boosting diagnostic accuracy. Amid these dynamics, a keen understanding of regional market demands and an agile approach to leveraging technological advancements will help businesses thrive in this market.

KEY MARKET STATISTICS
Base Year [2023] USD 201.25 million
Estimated Year [2024] USD 217.87 million
Forecast Year [2030] USD 361.87 million
CAGR (%) 8.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Molecular Quality Controls Market

The Molecular Quality Controls Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of infectious diseases and need for diseases testing
    • Government grants and funding for genomics
    • Increase in number of clinical laboratories and rising demand for multi-analyte controls
  • Market Restraints
    • Unfavorable reimbursement scenario and additional costs for quality control
  • Market Opportunities
    • Rising preferences for personalized medicine and third-party quality controls
    • Increasing potential with evolving landscape of molecular testing
  • Market Challenges
    • Lack of quality control materials, quantitative test system outputs, and the daily appearance of new genetic test targets

Porter's Five Forces: A Strategic Tool for Navigating the Molecular Quality Controls Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Molecular Quality Controls Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Molecular Quality Controls Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Molecular Quality Controls Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Molecular Quality Controls Market

A detailed market share analysis in the Molecular Quality Controls Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Molecular Quality Controls Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Molecular Quality Controls Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Molecular Quality Controls Market

A strategic analysis of the Molecular Quality Controls Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Molecular Quality Controls Market, highlighting leading vendors and their innovative profiles. These include Anchor Molecular Inc., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Fortress Diagnostics, Grifols S.A., LGC Limited, Maine Molecular Quality Controls, Inc., Microbiologics, Inc., Microbix Biosystems Inc., Qnostics Ltd., Quidel Corporation, Randox Laboratories Ltd., Seegene, Inc., SpeeDx Pty Ltd., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Molecular Quality Controls Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Independent Controls and Instrument-Specific Controls.
  • Based on Analyte Type, market is studied across Multi-Analyte Controls and Single-Analyte Controls.
  • Based on Application, market is studied across Genetic Testing, Infectious Diseases, and Oncology.
  • Based on End-User, market is studied across Academic & Research Institutes, Clinical Laboratories, Hospitals, and IVD Manufacturers & Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of infectious diseases and need for diseases testing
      • 5.1.1.2. Government grants and funding for genomics
      • 5.1.1.3. Increase in number of clinical laboratories and rising demand for multi-analyte controls
    • 5.1.2. Restraints
      • 5.1.2.1. Unfavorable reimbursement scenario and additional costs for quality control
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising preferences for personalized medicine and third-party quality controls
      • 5.1.3.2. Increasing potential with evolving landscape of molecular testing
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of quality control materials, quantitative test system outputs, and the daily appearance of new genetic test targets
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Molecular Quality Controls Market, by Product

  • 6.1. Introduction
  • 6.2. Independent Controls
  • 6.3. Instrument-Specific Controls

7. Molecular Quality Controls Market, by Analyte Type

  • 7.1. Introduction
  • 7.2. Multi-Analyte Controls
  • 7.3. Single-Analyte Controls

8. Molecular Quality Controls Market, by Application

  • 8.1. Introduction
  • 8.2. Genetic Testing
  • 8.3. Infectious Diseases
  • 8.4. Oncology

9. Molecular Quality Controls Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Clinical Laboratories
  • 9.4. Hospitals
  • 9.5. IVD Manufacturers & Contract Research Organizations

10. Americas Molecular Quality Controls Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Molecular Quality Controls Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Molecular Quality Controls Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anchor Molecular Inc.
  • 2. Bio-Rad Laboratories, Inc.
  • 3. Bio-Techne Corporation
  • 4. Fortress Diagnostics
  • 5. Grifols S.A.
  • 6. LGC Limited
  • 7. Maine Molecular Quality Controls, Inc.
  • 8. Microbiologics, Inc.
  • 9. Microbix Biosystems Inc.
  • 10. Qnostics Ltd.
  • 11. Quidel Corporation
  • 12. Randox Laboratories Ltd.
  • 13. Seegene, Inc.
  • 14. SpeeDx Pty Ltd.
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. MOLECULAR QUALITY CONTROLS MARKET RESEARCH PROCESS
  • FIGURE 2. MOLECULAR QUALITY CONTROLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MOLECULAR QUALITY CONTROLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MOLECULAR QUALITY CONTROLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MOLECULAR QUALITY CONTROLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MOLECULAR QUALITY CONTROLS MARKET DYNAMICS
  • TABLE 7. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY INDEPENDENT CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY INSTRUMENT-SPECIFIC CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY MULTI-ANALYTE CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY SINGLE-ANALYTE CONTROLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY IVD MANUFACTURERS & CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY ANALYTE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM MOLECULAR QUALITY CONTROLS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. MOLECULAR QUALITY CONTROLS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. MOLECULAR QUALITY CONTROLS MARKET, FPNV POSITIONING MATRIX, 2023